QUIA — QUIA PHARMA AB (publ) Cashflow Statement
0.000.00%
- SEK35.69m
- SEK35.68m
Annual cashflow statement for QUIA PHARMA AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -24.9 | -17.6 | -15.8 | -15.5 | -28.7 |
Depreciation | |||||
Non-Cash Items | 1.34 | — | — | 0.326 | 19 |
Other Non-Cash Items | |||||
Changes in Working Capital | -4.72 | -4.74 | -5.75 | 1.06 | -0.458 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -28.3 | -20.1 | -18.2 | -10.3 | -10.2 |
Capital Expenditures | -2.51 | -8.59 | -5.57 | -24.4 | -0.46 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.001 | — | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.5 | -8.59 | -5.57 | -24.4 | -0.46 |
Financing Cash Flow Items | — | — | — | — | 6.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 34.9 | 25.5 | 21 | 32.2 | 10.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.04 | -3.25 | -2.77 | -2.46 | -0.099 |